531 related articles for article (PubMed ID: 21211275)
21. Gestational trophoblastic disease: a 21-year review of the clinical experience at an Argentinean public hospital.
Bianconi MI; Otero S; Moscheni O; Alvarez L; Storino C; Jankilevich G
J Reprod Med; 2012; 57(7-8):341-9. PubMed ID: 22838252
[TBL] [Abstract][Full Text] [Related]
22. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis.
Alifrangis C; Agarwal R; Short D; Fisher RA; Sebire NJ; Harvey R; Savage PM; Seckl MJ
J Clin Oncol; 2013 Jan; 31(2):280-6. PubMed ID: 23233709
[TBL] [Abstract][Full Text] [Related]
23. Outcomes for relapsed versus resistant low risk gestational trophoblastic neoplasia following single-agent chemotherapy.
Jareemit N; Horowitz NS; Goldstein DP; Berkowitz RS; Elias KM
Gynecol Oncol; 2020 Dec; 159(3):751-757. PubMed ID: 33023756
[TBL] [Abstract][Full Text] [Related]
24. Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia.
Feng F; Xiang Y; Wan X; Geng S; Wang T
Ann Oncol; 2011 Jul; 22(7):1588-1594. PubMed ID: 21239399
[TBL] [Abstract][Full Text] [Related]
25. The added value of hysterectomy in the management of gestational trophoblastic neoplasia.
Eysbouts YK; Massuger LFAG; IntHout J; Lok CAR; Sweep FCGJ; Ottevanger PB
Gynecol Oncol; 2017 Jun; 145(3):536-542. PubMed ID: 28390821
[TBL] [Abstract][Full Text] [Related]
26. Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital.
Cagayan MS; Lu-Lasala LR
J Reprod Med; 2006 Oct; 51(10):785-92. PubMed ID: 17086807
[TBL] [Abstract][Full Text] [Related]
27. Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.
Lurain JR; Chapman-Davis E; Hoekstra AV; Schink JC
J Reprod Med; 2012; 57(7-8):283-7. PubMed ID: 22838241
[TBL] [Abstract][Full Text] [Related]
28. Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years.
Fülöp V; Szigetvári I; Szepesi J; Végh G; Singh M; Berkowitz RS
J Reprod Med; 2012; 57(7-8):310-8. PubMed ID: 22838247
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Clinical Characteristics and Outcomes in 7 Patients with Re-recurrent Gestational Trophoblastic Neoplasia.
Li B; Wan X; Liang Y; Lu B; Lu W
J Reprod Med; 2016 Sep; 61(9-10):494-502. PubMed ID: 30383951
[TBL] [Abstract][Full Text] [Related]
30. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
Lurain JR; Nejad B
Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
[TBL] [Abstract][Full Text] [Related]
31. Human Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia.
Rattanaburi A; Boonyapipat S; Supasinth Y
Asian Pac J Cancer Prev; 2015; 16(12):5037-41. PubMed ID: 26163637
[TBL] [Abstract][Full Text] [Related]
32. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
[No Abstract] [Full Text] [Related]
33. Combined methotrexate-dactinomycin: an effective therapy for low-risk gestational trophoblastic neoplasia.
Eiriksson L; Wells T; Steed H; Schepansky A; Capstick V; Hoskins P; Pike J; Swenerton K
Gynecol Oncol; 2012 Mar; 124(3):553-7. PubMed ID: 22079360
[TBL] [Abstract][Full Text] [Related]
34. The WHO score predicts treatment outcome in low risk gestational trophoblastic neoplasia patients treated with weekly intramuscular methotrexate.
Gilani MM; Fariba B; Behtash N; Ghaemmaghami F; Moosavi AS; Rezayof E
J Cancer Res Ther; 2013; 9(1):38-43. PubMed ID: 23575072
[TBL] [Abstract][Full Text] [Related]
35. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the response to chemotherapy in gestational trophoblastic neoplasia with vaginal metastases.
Ghaemmaghami F; Behroozi S; Mousavi A; Ashrafgangooei T; Gilani MM; Behtash N; Ghanbari Z
Arch Gynecol Obstet; 2008 Oct; 278(4):315-8. PubMed ID: 18293004
[TBL] [Abstract][Full Text] [Related]
37. High-risk metastatic gestational trophoblastic neoplasia. Primary management with EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy.
Cagayan MS
J Reprod Med; 2012; 57(5-6):231-6. PubMed ID: 22696818
[TBL] [Abstract][Full Text] [Related]
38. Methotrexate, bleomycin, and Etoposide in the treatment of gestational trophoblastic neoplasia.
Ngan HY; Tam KF; Lam KW; Chan KK
Obstet Gynecol; 2006 May; 107(5):1012-7. PubMed ID: 16648404
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy of FAEV regimen in treatment of high-risk drug-resistant gestational trophoblastic tumor].
Wan XR; Xiang Y; Yang XY; Wu Y; Liu N; Chen L; Dong RF
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):88-90. PubMed ID: 16640854
[TBL] [Abstract][Full Text] [Related]
40. Response to chemotherapy in overweight/obese patients with low-risk gestational trophoblastic neoplasia.
Maestá I; Horowitz NS; Goldstein DP; Bernstein MR; Ramírez LA; Moulder J; Berkowitz RS
Int J Gynecol Cancer; 2015 May; 25(4):734-40. PubMed ID: 25675037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
